| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Circulation
|
2004
|
23.07
|
|
2
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
|
Circulation
|
2006
|
8.01
|
|
3
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
|
J Am Coll Cardiol
|
2004
|
6.50
|
|
4
|
ACC/AHA/NHLBI clinical advisory on the use and safety of statins.
|
J Am Coll Cardiol
|
2002
|
4.50
|
|
5
|
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
|
J Am Coll Cardiol
|
2003
|
3.76
|
|
6
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
Circulation
|
2004
|
3.39
|
|
7
|
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
|
Circulation
|
2002
|
3.29
|
|
8
|
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
|
Circulation
|
2003
|
3.16
|
|
9
|
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).
|
Circulation
|
2005
|
3.01
|
|
10
|
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
|
J Am Coll Cardiol
|
2007
|
2.95
|
|
11
|
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.
|
Am Heart J
|
2008
|
2.26
|
|
12
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
Am J Cardiol
|
2005
|
2.11
|
|
13
|
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
|
Stroke
|
2002
|
1.93
|
|
14
|
Ethnic differences in C-reactive protein concentrations.
|
Clin Chem
|
2008
|
1.87
|
|
15
|
2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
|
Circulation
|
2007
|
1.84
|
|
16
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.70
|
|
17
|
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN).
|
Am Heart J
|
2005
|
1.67
|
|
18
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
J Am Coll Cardiol
|
2004
|
1.59
|
|
19
|
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy.
|
Am J Cardiol
|
2010
|
1.53
|
|
20
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.49
|
|
21
|
Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology.
|
Circulation
|
2004
|
1.42
|
|
22
|
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management.
|
Circulation
|
2004
|
1.39
|
|
23
|
Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation.
|
Am J Epidemiol
|
2009
|
1.29
|
|
24
|
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association.
|
Circulation
|
2004
|
1.24
|
|
25
|
The ALLHAT lipid lowering trial--less is less.
|
JAMA
|
2002
|
1.17
|
|
26
|
Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference.
|
J Am Coll Cardiol
|
2002
|
1.16
|
|
27
|
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
|
J Clin Endocrinol Metab
|
2006
|
1.14
|
|
28
|
Bupropion for smokers hospitalized with acute cardiovascular disease.
|
Am J Med
|
2006
|
1.13
|
|
29
|
Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease.
|
Arch Intern Med
|
2008
|
1.13
|
|
30
|
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
|
Am Heart J
|
2010
|
1.01
|
|
31
|
Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey.
|
Arch Intern Med
|
2003
|
1.00
|
|
32
|
Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
|
Am J Cardiol
|
2009
|
0.98
|
|
33
|
Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of Women's Health Across the Nation.
|
Hypertension
|
2005
|
0.95
|
|
34
|
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.94
|
|
35
|
Application of national screening criteria for blood pressure and cholesterol to perimenopausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation.
|
Prev Cardiol
|
2006
|
0.83
|
|
36
|
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management.
|
Stroke
|
2004
|
0.83
|
|
37
|
Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.
|
Circ Cardiovasc Imaging
|
2010
|
0.81
|
|
38
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.81
|
|
39
|
Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness.
|
Clin Trials
|
2009
|
0.78
|
|
40
|
Letter by Pasternak and Cahill regarding article, "Manuscript preparation and publication".
|
Circulation
|
2010
|
0.75
|
|
41
|
Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
|
Circulation
|
2009
|
0.75
|
|
42
|
ALLHAT-LLT: questions, questions, and more questions (and some answers).
|
Curr Atheroscler Rep
|
2004
|
0.75
|